|
CN112125915A
|
|
Camptothecin derivative and conjugate thereof
|
|
CN111686259A
|
|
SN 38-containing antibody drug conjugate
|
|
CN111689980A
|
|
Camptothecin drug and antibody conjugate thereof
|
|
CN110974975A
|
|
Quick-release antibody drug conjugate
|
|
CN111001012A
|
|
Hydrophilic carbonate type antibody coupling drug
|
|
CN108853514A
|
|
There are two types of the antibody drug conjugates of different pharmaceutical for tool
|
|
CN109180681A
|
|
A kind of DNA toxicity dimer compound
|
|
AU2018295118A1
|
|
Multi-specific antibodies and methods of making and using thereof
|
|
CN108743968A
|
|
Cysteine engineered Antibody-toxin conjugate (TDC) site-directed coupling site screening
|
|
CN108714220A
|
|
Cysteine engineered Antibody-toxin conjugate
|
|
CN108727498A
|
|
Cysteine engineered Antibody-toxin conjugate
|
|
CN108743966A
|
|
Cysteine engineered Antibody-toxin conjugate
|
|
CN108727499A
|
|
Cysteine engineered Antibody-toxin conjugate
|
|
CN108743956A
|
|
A kind of albumin combination type anthracene nucleus antineoplastic antibiotic preparation and preparation method thereof
|
|
CN107789630A
|
|
Cysteine engineered antibody toxin conjugate and preparation method thereof
|
|
CN107118271A
|
|
Antigen polypeptide and monoclonal antibody available for enrichment people's L1CAM albumen
|
|
CN106866822A
|
|
Cysteine engineered antibody toxin conjugate
|
|
CN107056762A
|
|
A kind of double carbonyl analogs as resisiting influenza virus
|
|
CN105906621A
|
|
Ethanol compound used as FGFR inhibitor
|
|
CN105906630A
|
|
N-(1H-pyrazol-5-yl)pyrimidopyrazole-4,6-di-substituted amine compound used as FGFR inhibitor
|
